Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances

Proceedings from a webinar on March 11, 2026, moderated by Dr Neil Love, including the following topics:

• Introduction: I think I missed that day in med school (BTK biology) (0:00)
• First-Line Treatment (11:40)
• Relapsed/Refractory Disease (46:35)

CME information and select publications